Body mass index, tumor characteristics, and prognosis following diagnosis of early-stage breast cancer in a mammographically screened population

Cancer Causes and Control

Volumn 24, Issue 2, 2013, Pages 305-312

  Kamineni, Aruna ^a   Anderson, Melissa L ^a   White, Emily ^b,c   Taplin, Stephen H ^d   Porter, Peggy ^b   Ballard Barbash, Rachel ^d   Malone, Kathleen ^b,c   Buist, Diana S M ^a  

^a GROUP HEALTH RESEARCH INSTITUTE   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Body mass index; Breast cancer recurrence; Breast cancer specific mortality; Obesity; Tumor characteristics

Indexed keywords

CYCLIN E; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; KI 67 ANTIGEN; PROGESTERONE RECEPTOR; PROTEIN BCL 2; PROTEIN P27; PROTEIN P53; TUMOR MARKER;

ADULT; ARTICLE; BODY MASS; BREAST CANCER; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SCREENING; CANCER STAGING; COHORT ANALYSIS; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MEDICAL RECORD; OBESITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RECURRENCE RISK; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; BODY MASS INDEX; BREAST NEOPLASMS; COHORT STUDIES; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MAMMOGRAPHY; MIDDLE AGED; OBESITY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME; WASHINGTON;

EID: 84878868939     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-012-0115-7     Document Type: Article

References (48)

1. Goodwin PJ, Boyd NF (1990) Body size and breast cancer prognosis: a critical review of the evidence. Breast Cancer Res Treat 16:205-214
2. Greenberg ER, Vessey MP, McPherson K, Doll R, Yeates D (1985) Body size and survival in premenopausal breast cancer. Br J Cancer 51:691-697
3. Holmberg L, Lund E, Bergstrom R, Adami HO, Meirik O (1994) Oral contraceptives and prognosis in breast cancer: effects of duration, latency, recency, age at first use and relation to parity and body mass index in young women with breast cancer. Eur J Cancer 30A:351-354
4. Daling JR, Malone KE, Doody DR, Johnson LG, Gralow JR, Porter PL (2001) Relation of body mass index to tumor markers and survival among young women with invasive ductal breast carcinoma. Cancer 92:720-729
5. Zhang S, Folsom AR, Sellers TA, Kushi LH, Potter JD (1995) Better breast cancer survival for postmenopausal women who are less overweight and eat less fat. The Iowa Women's Health Study. Cancer 76:275-283
6. Chang S, Alderfer JR, Asmar L, Buzdar AU (2000) Inflammatory breast cancer survival: the role of obesity and menopausal status at diagnosis. Breast Cancer Res Treat 64:157-163
7. Ewertz M, Jensen MB, Gunnarsdottir KA, et al. (2011) Effect of obesity on prognosis after early-stage breast cancer. J Clin Oncol 29:25-31
8. Senie RT, Rosen PP, Rhodes P, Lesser ML, Kinne DW (1992) Obesity at diagnosis of breast carcinoma influences duration of disease-free survival. Ann Intern Med 116:26-32
9. Chlebowski RT, Aiello E, McTiernan A (2002) Weight loss in breast cancer patient management. J Clin Oncol 20:1128-1143
10. Maehle BO, Tretli S (1996) Pre-morbid body-mass-index in breast cancer: reversed effect on survival in hormone receptor negative patients. Breast Cancer Res Treat 41:123-130
11. Newman SC, Lees AW, Jenkins HJ (1997) The effect of body mass index and oestrogen receptor level on survival of breast cancer patients. Int J Epidemiol 26:484-490
12. Williams G, Howell A, Jones M (1988) The relationship of body weight to response to endocrine therapy, steroid hormone receptors and survival of patients with advanced cancer of the breast. Br J Cancer 58:631-634
13. Obermair A, Kurz C, Hanzal E, et al. (1995) The influence of obesity on the disease-free survival in primary breast cancer. Anticancer Res 15:2265-2269
14. Dignam JJ, Wieand K, Johnson KA, Fisher B, Xu L, Mamounas EP (2003) Obesity, tamoxifen use, and outcomes in women with estrogen receptor-positive early-stage breast cancer. J Natl Cancer Inst 95:1467-1476
15. den Tonkelaar I, de Waard F, Seidell JC, Fracheboud J (1995) Obesity and subcutaneous fat patterning in relation to survival of postmenopausal breast cancer patients participating in the DOM-project. Breast Cancer Res Treat 34:129-137
16. Katoh A, Watzlaf VJ, D'Amico F (1994) An examination of obesity and breast cancer survival in post-menopausal women. Br J Cancer 70:928-933
17. Carmichael AR, Bendall S, Lockerbie L, Prescott RJ, Bates T (2004) Does obesity compromise survival in women with breast cancer? Breast 13:93-96
18. Caan BJ, Emond JA, Natarajan L, et al. (2006) Post-diagnosis weight gain and breast cancer recurrence in women with early stage breast cancer. Breast Cancer Res Treat 99:47-57
19. Taplin SH, Mandelson MT, Anderman C, et al. (1997) Mammography diffusion and trends in late-stage breast cancer: evaluating outcomes in a population. Cancer Epidemiol Biomarkers Prev 6:625-631
20. Taplin SH, Thompson RS, Schnitzer F, Anderman C, Immanuel V (1990) Revisions in the risk-based Breast Cancer Screening Program at Group Health Cooperative. Cancer 66:812-818
21. Taplin SH, Ichikawa L, Yood MU, et al. (2004) Reason for late-stage breast cancer: absence of screening or detection, or breakdown in follow-up? J Natl Cancer Inst 96:1518-1527
22. Fleming ID, Cooper JS, Henson DE, et al. (eds) (1997) AJCC Cancer Staging Manual, 5th edn. Lippincott Williams & Wilkins, Philadelphia
23. Buist DS, Porter PL, Lehman C, Taplin SH, White E (2004) Factors contributing to mammography failure in women aged 40-49 years. J Natl Cancer Inst 96:1432-1440
24. Porter PL, El-Bastawissi AY, Mandelson MT, et al. (1999) Breast tumor characteristics as predictors of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst 91:2020-2028
25. WHO (2000) Obesity: preventing and managing the global epidemic. World Health Organization, Geneva (Switzerland)
26. American College of Radiology (ACR) (2003) ACR BI-RADS - mammography ACR Breast Imaging and Reporting and Data System, Breast Imaging Atlas, 4th edn. American College of Radiology, Reston
27. Rutter CM, Mandelson MT, Laya MB, Seger DJ, Taplin S (2001) Changes in breast density associated with initiation, discontinuation, and continuing use of hormone replacement therapy. JAMA 285:171-176
28. Buist DS, Chubak J, Prout M, et al. (2009) Referral, receipt, and completion of chemotherapy in patients with early-stage breast cancer older than 65 years and at high risk of breast cancer recurrence. J Clin Oncol 27:4508-4514
29. Geiger AM, Thwin SS, Lash TL, et al. (2007) Recurrences and second primary breast cancers in older women with initial early-stage disease. Cancer 109:966-974
30. Yood MU, Owusu C, Buist DS, et al. (2008) Mortality impact of less-than-standard therapy in older breast cancer patients. J Am Coll Surg 206:66-75
31. Zou G (2004) A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol 159:702-706
32. Rosner GL, Hargis JB, Hollis DR, et al. (1996) Relationship between toxicity and obesity in women receiving adjuvant chemotherapy for breast cancer: results from cancer and leukemia group B study 8541. J Clin Oncol 14:3000-3008
33. Griggs JJ, Culakova E, Sorbero ME, et al. (2007) Effect of patient socioeconomic status and body mass index on the quality of breast cancer adjuvant chemotherapy. J Clin Oncol 25:277-284
34. Mannisto S, Pietinen P, Pyy M, Palmgren J, Eskelinen M, Uusitupa M (1996) Body-size indicators and risk of breast cancer according to menopause and estrogen-receptor status. Int J Cancer 68:8-13
35. Ruder AM, Lubin F, Wax Y, Geier A, Alfundary E, Chetrit A (1989) Estrogen and progesterone receptors in breast cancer patients. Epidemiologic characteristics and survival differences. Cancer 64:196-202
36. Giuffrida D, Lupo L, La Porta GA, et al. (1992) Relation between steroid receptor status and body weight in breast cancer patients. Eur J Cancer 28:112-115
37. Howson CP, Kinne D, Wynder EL (1986) Body weight, serum cholesterol, and stage of primary breast cancer. Cancer 58:2372-2381
38. Enger SM, Ross RK, Paganini-Hill A, Carpenter CL, Bernstein L (2000) Body size, physical activity, and breast cancer hormone receptor status: results from two case-control studies. Cancer Epidemiol Biomarkers Prev 9:681-687
39. Elmore JG, Carney PA, Abraham LA, et al. (2004) The association between obesity and screening mammography accuracy. Arch Intern Med 164:1140-1147
40. Carney PA, Harwood BG, Weiss JE, Eliassen MS, Goodrich ME (2002) Factors associated with interval adherence to mammography screening in a population-based sample of New Hampshire women. Cancer 95:219-227
41. Fontaine KR, Heo M, Allison DB (2001) Body weight and cancer screening among women. J Womens Health Gend Based Med 10:463-470
42. Wee CC, McCarthy EP, Davis RB, Phillips RS (2000) Screening for cervical and breast cancer: is obesity an unrecognized barrier to preventive care? Ann Intern Med 132:697-704
43. Caan BJ, Aragaki A, Thomson CA, et al. (2009) Vasomotor symptoms, adoption of a low-fat dietary pattern, and risk of invasive breast cancer: a secondary analysis of the Women's Health Initiative randomized controlled dietary modification trial. J Clin Oncol 27:4500-4507
44. Kaplan MA, Pekkolay Z, Kucukoner M, et al. (2012) Type 2 diabetes mellitus and prognosis in early stage breast cancer women. Med Oncol 29:1576-1580
45. Patterson RE, Flatt SW, Saquib N, et al. (2010) Medical comorbidities predict mortality in women with a history of early stage breast cancer. Breast Cancer Res Treat 122:859-865
46. Lipscombe LL, Goodwin PJ, Zinman B, McLaughlin JR, Hux JE (2008) The impact of diabetes on survival following breast cancer. Breast Cancer Res Treat 109:389-395
47. National Comprehensive Cancer Network (2012) NCCN clinical practice guidelines in oncology (NCCN guidelines) breast cancer version 3, 2012th edn. National Comprehensive Cancer Network, Fort Washington
48. Nekhlyudov L, Li L, Ross-Degnan D, Wagner AK (2011) Five-year patterns of adjuvant hormonal therapy use, persistence, and adherence among insured women with early-stage breast cancer. Breast Cancer Res Treat 130:681-689